US Food and Drug Administration (FDA)

Artelus

Artelus designs deep learning solutions to complement the knowledge of and assist the clinician in making faster and more accurate diagnoses. The company focuses on early diagnosis of DR in at-risk patients that are not yet showing symptoms, as treatment is often ineffective once symptoms appear.

Wearables: 5 Key Conclusions From IDTechEx's Latest Research

2019 saw the largest single year growth rate for wearable technology product revenue since 2015

Global Differences in Regulation for Genetic Engineering

Innovation roadmap for the report 'Genetic Engineering in Agriculture 2021-2031'.

Bioelectronic Therapy to Jump Start Peripheral Nerve Regeneration

This therapy utilizes brief electrical stimulation of injured nerves to upregulate regeneration associated genes and accelerate the creation of the building blocks that form new regenerating nerves. The company's wearable technology was designated a breakthrough device by the FDA in recognition of the impact it may have on the recovery of patients suffering from peripheral nerve injuries and the shift this device will bring about in the therapeutic industry.

Philips Launches Wearable for Early Patient Deterioration, COVID 19

The Philips Biosensor is designed to address a new approach to vital signs measurements, supporting surveillance of higher acuity patients moving from intensive care units into lower acuity general care areas of a hospital. The lightweight, disposable biosensor is a 5-day, single-use wearable patch which can be integrated with a scalable hub to monitor multiple patients across multiple rooms.

CRISPR Plants: New Non-GMO Method to Edit Plants

An NC State researcher has developed a new way to get CRISPR/Cas9 into plant cells without inserting foreign DNA. This allows for precise genetic deletions or replacements, without inserting foreign DNA. Therefore, the end product is not a genetically modified organism, or GMO.

Aktiia Cuffless Blood Pressure Monitor Proven Accurate

Aktiia has developed a wrist-worn optical blood pressure monitor that can automatically take measurements around the clock without requiring a specific arm position.

Trial of Bioelectronic Platform in Rheumatoid Arthritis Patients

SetPoint Medical has received Investigational Device Exemption approval from the US Food and Drug Administration to study its proprietary bioelectronic platform in patients with rheumatoid arthritis.

Miiskin

The Miiskin app allows users to locate, capture and compare their moles over time. A video in the app guides the user to perform a full-body skin self-exam with or without the help of a partner. The app allows the user to take close-up photographs of individual lesions and wide area photos of their skin, for example of their back.

MetaOptima

MetaOptima is a digital health tech company focused on dermatology. Its technology, a smartphone app and online platform, enables the tracking and mapping of moles on users' skin in order to predict and prevent skin cancer. The company offers two products designed to enhance standards of patient care while streamlining services for maximum efficiency: DermEngine and MoleScope.

SkinVision

SkinVision has developed a smartphone app that allows users to understand their risk factors for skin cancer (including melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis). It enables users to detect skin cancer at an early stage as well as to keep track of their moles over time in order to monitor their evolution. SkinVision does not formally provide a diagnosis, but instead a risk assessment and recommendation.

Intrasense

Intrasense aims to accelerate and leverage the use and interpretation of medical images (CT, MRI and X-ray) throughout the chain of care. This ranges from research, to screening, to diagnosis, to treatment planning, as well as lesions follow-up.

Telehealth Rises to the Challenge During the COVID-19 Crisis

Telehealth has been poised to disrupt healthcare for many years, but unfortunately has faced a slow rise in adoption. This has changed in the COVID-19 crisis.

Partnership for 3D Pharmaceutical Printing

Health care is poised for a potential giant leap forward thanks to the 3D printing of medications. To advance the technology and science of 3D pharmaceutical printing, Purdue University's College of Pharmacy and Aprecia Pharmaceuticals, LLC are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.

Arterys

Arterys was founded to facilitate the global advancement of medicine through data, AI and technology. Its mission is to transform the world of medical imaging via high performance cloud computation.

Quantib

Quantib's software is able to detect abnormalities that radiologists can't see with the naked eye. The company makes all the information captured in medical images available to radiologists, so they can detect diseases before symptoms start showing. The AI algorithms developed by Quantib help to identify specific brain disorders months before radiologists could perceive them using conventional methods.

Therapixel

Therapixel applies artificial intelligence (AI) to medical imaging. Using various forms of AI, the company develops products to help healthcare professionals access images more easily and gain more value from them.

ArtiQ

ArtiQ aims to support doctors in the diagnosis, treatment and follow-up of respiratory diseases. With its first artificial intelligence-based software, ArtiQ.PFT, it supports the interpretation of pulmonary function tests (PFTs) and improves the diagnostic environment for lung diseases.

Lunit

Lunit, abbreviated from "learning unit," is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology. The company was founded in 2013 by six scientists from Korea Advanced Institute of Science and Technology (KAIST). Its initial interest was breast cancer, but the company has now moved to all kinds of chest diseases. Its end goal is to provide more AI solutions to enable the earlier diagnosis of disease or to predict its onset altogether. It focuses on oncology and radiology.

Subtle Medical

Unlike most AI radiology companies, Subtle Medical focuses on image acquisition rather than analysis. It is developing software solutions to improve the capture of high-quality medical images. More specifically, it transforms low resolution scans taken rapidly (eg: in 6 minutes) into high resolution scans that normally can only be obtained by running scans for 20+ minutes.